Brief: Chordate Medical Gets Market Authorization For Migraine Indication
Oct 14 (Reuters) - Chordate Medical Holding AB (publ)
CMHM.ST :
* CHORDATE MEDICAL RECEIVES MARKET AUTHORIZATION FOR THE
MIGRAINE
INDICATION IN SAUDI ARABIA
Source text for Eikon: ID:nMFN5Hw4hr
Further company coverage: CMHM.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Chordate Medical Holding AB (publ)
See all newsBrief: Chordate Applies For Delisting
Brief: Chordate Medical Holding Says Last Day Of Trading Is In March 2026
Brief: Chordate Medical To Enter Into Voluntary Liquidation
Brief: Chordate Board Proposes AGM To Resolve On Voluntary Liquidation And Delisting
Brief: Chordate Medical Holding Q2 Net Loss SEK 5.2 Mln